• 1. An atomic scale study of defects in Co2FeAl
  Ravi Kumar Yadav,R. Govindaraj Phys. Chem. Chem. Phys., 2020,22, 26876-26886
• 2. An atom efficient route to N-aryl and N-alkyl pyrrolines by transition metal catalysis?
  Supaporn Sawadjoon,Joseph S. M. Samec Org. Biomol. Chem., 2011,9, 2548-2554
• 3. An analysis of the WTC fires using CIB correlations and simple modeling
  JGQuintiere
• 4. An Appraisal of pH triggered Bacitracin drug release, through composite hydrogel systems
  RabailGul,MariamMir,MurtazaNAli
• 5. An atlas of endohedral Sc2S cluster fullerenes?
  Li-Hua Gan,Rui Wu,Jian-Lei Tian,Patrick W. Fowler Phys. Chem. Chem. Phys., 2017,19, 419-425

Comprehensive Overview of N-(2-Benzoylphenyl)-1-benzylpyrrolidine-2-carboxamide;hydrochloride (CAS No. 147959-98-6)

N-(2-Benzoylphenyl)-1-benzylpyrrolidine-2-carboxamide;hydrochloride (CAS No. 147959-98-6) is a synthetic organic compound that has garnered significant attention in pharmaceutical and biochemical research due to its unique structural properties and potential applications. This compound, often referred to by its CAS number 147959-98-6, belongs to the class of pyrrolidine carboxamides, which are known for their diverse biological activities. The presence of both benzoyl and benzyl groups in its structure enhances its reactivity and makes it a valuable intermediate in drug discovery.

In recent years, the demand for N-(2-Benzoylphenyl)-1-benzylpyrrolidine-2-carboxamide;hydrochloride has increased, particularly in the context of targeted drug delivery and enzyme inhibition studies. Researchers are exploring its potential as a modulator of protein-protein interactions, a hot topic in modern pharmacology. Its hydrochloride salt form improves solubility, making it more suitable for in vitro and in vivo assays. This aligns with the growing trend of optimizing drug candidates for better bioavailability, a frequently searched topic in AI-driven drug development platforms.

The compound's molecular structure features a pyrrolidine ring linked to a benzoylphenyl moiety, which contributes to its stereochemical complexity. This complexity is a key focus area for researchers investigating chiral drug synthesis, a trending subject in organic chemistry forums and academic publications. The benzyl group further enhances its lipophilicity, a property often discussed in drug design optimization queries on search engines.

From a synthetic perspective, CAS 147959-98-6 is typically prepared through multi-step organic reactions, including amide coupling and N-alkylation. These methods are widely covered in patent literature and research papers, reflecting the compound's industrial relevance. Its purity and stability are critical for applications in high-throughput screening, a technique frequently searched by biotech professionals and pharmaceutical scientists.

In the context of current research trends, N-(2-Benzoylphenyl)-1-benzylpyrrolidine-2-carboxamide;hydrochloride is being studied for its potential role in neurodegenerative disease models. This aligns with the surge in public interest around brain health supplements and cognitive enhancers. While the compound itself is not a commercial supplement, its structural analogs are often explored in nootropic research, a popular topic in health and wellness communities.

The analytical characterization of this compound involves advanced techniques such as NMR spectroscopy, mass spectrometry, and HPLC purity analysis. These methods are frequently queried by quality control specialists and process chemists, highlighting the compound's importance in pharmaceutical manufacturing. Its spectral data is often shared in open-access chemistry databases, catering to the growing demand for transparent research data.

As the pharmaceutical industry shifts toward personalized medicine, compounds like N-(2-Benzoylphenyl)-1-benzylpyrrolidine-2-carboxamide;hydrochloride gain prominence due to their potential as scaffolds for targeted therapies. This connects with the increasing search volume for precision medicine and biomarker discovery topics. The compound's structure-activity relationship (SAR) is a subject of ongoing investigation, particularly in computational chemistry circles where molecular docking simulations are frequently discussed.

From a regulatory standpoint, CAS 147959-98-6 is not classified as a controlled substance, making it accessible for legitimate research purposes. However, researchers must adhere to Good Laboratory Practices (GLP) when handling this material, a requirement often searched by compliance officers in the life sciences sector. The compound's material safety data is available through chemical regulatory databases, addressing common queries about safe handling procedures.

In conclusion, N-(2-Benzoylphenyl)-1-benzylpyrrolidine-2-carboxamide;hydrochloride (CAS No. 147959-98-6) represents a versatile research chemical with broad applicability in medicinal chemistry and drug discovery. Its relevance to current pharmaceutical challenges and alignment with popular scientific inquiries make it a compound of enduring interest. As research continues to uncover its potential, this molecule may play a pivotal role in addressing some of the most pressing questions in contemporary biomedical science.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)